CD274 and neoplasm: This approach can enhance antibody-dependent cell-mediated cytotoxicity-mediated anti-tumor activity, boost cytokine production, and inhibit NK cell apoptosis in PD-L1-positive GCs and other gastrointestinal malignancies.